Active	Status	Sponsor type	Region	Phase	Filter
14 Active 1 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   - « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

14 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gutierrez, Anya
NCT05894577: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)	Completed	3	1453	US	Placebo, Montelukast	Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center	Covid19	07/23	01/24
NCT04885530: ACTIV-6: COVID-19 Study of Repurposed Medications	Completed	3	10956	US	Ivermectin, Ivermectin Tablets, Fluvoxamine, Fluvoxamine Maleate Tablets, Fluticasone, Fluticasone Furoate, Placebo, Montelukast, Metformin	Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center	Covid19	04/24	04/24
NCT06042855: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)	Completed	3	3214	US	Placebo, Metformin	Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center	Covid19	06/24	11/24
NCT04247542: ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection	Completed	2	53	US	Ibezapolstat, ACX-362E, Vancomycin, Vancomycin oral	Acurx Pharmaceuticals Inc.	Clostridium Difficile Infection	10/23	11/23
BOSS-002, NCT05785390: Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.	Terminated	2	170	US	NP-101, TQ Formula, Placebo	Novatek Pharmaceuticals	COVID-19	05/25	05/25
NCT05732610: MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study	Completed	N/A	34	US	MGC Health COVID-19 & Flu A+B Home Multi Test, MGC Health COVID-19 & Flu A+B Home Multi Test (2 to 13 y/o)	Medical Group Care, LLC, CSSi Life Sciences	COVID-19, Influenza A, Influenza B	02/23	03/23
NCT05771714: Clinical Performance Evaluation of the CareSuperb™ COVID-19 Antigen Home Test	Terminated	N/A	786	US	CareSuperb COVID-19 Antigen Home Test Kit	AccessBio, Inc.	COVID-19	05/23	05/23
ARGONAUT, NCT04638751: Stool and Blood Sample Bank for Cancer Patients	Recruiting	N/A	5000	US	Immunotherapy, Chemotherapy, CRC surgical resection, Colonoscopy	Persephone Biosciences	Non-small Cell Lung Cancer, Colorectal Cancer, Triple Negative Breast Cancer, Pancreas Cancer	12/24	12/25
Villa, Enrique
NCT06372496: Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma	Active, not recruiting	4	1358	Canada, Japan, US, RoW	Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate, Inhaled corticosteroids/long-acting beta-2 agonists	GlaxoSmithKline	Asthma	09/25	03/26
NCT05334758: Clinical Performance Evaluation of the Bio-Self™ COVID-19 Antigen Home Test	Completed	N/A	282	US	Bio-Self COVID-19 Antigen Home Test, Standard of Care COVID-19 Test, RT-PCR Test	BioTeke USA, LLC, CSSi Life Sciences	COVID-19	07/22	07/22
NCT05732610: MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study	Completed	N/A	34	US	MGC Health COVID-19 & Flu A+B Home Multi Test, MGC Health COVID-19 & Flu A+B Home Multi Test (2 to 13 y/o)	Medical Group Care, LLC, CSSi Life Sciences	COVID-19, Influenza A, Influenza B	02/23	03/23
NCT05771714: Clinical Performance Evaluation of the CareSuperb™ COVID-19 Antigen Home Test	Terminated	N/A	786	US	CareSuperb COVID-19 Antigen Home Test Kit	AccessBio, Inc.	COVID-19	05/23	05/23
ARGONAUT, NCT04638751: Stool and Blood Sample Bank for Cancer Patients	Recruiting	N/A	5000	US	Immunotherapy, Chemotherapy, CRC surgical resection, Colonoscopy	Persephone Biosciences	Non-small Cell Lung Cancer, Colorectal Cancer, Triple Negative Breast Cancer, Pancreas Cancer	12/24	12/25
Kim, Hyeonsuk
NCT05771714: Clinical Performance Evaluation of the CareSuperb™ COVID-19 Antigen Home Test	Terminated	N/A	786	US	CareSuperb COVID-19 Antigen Home Test Kit	AccessBio, Inc.	COVID-19	05/23	05/23

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gutierrez, Anya
NCT05894577: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)	Completed	3	1453	US	Placebo, Montelukast	Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center	Covid19	07/23	01/24
NCT04885530: ACTIV-6: COVID-19 Study of Repurposed Medications	Completed	3	10956	US	Ivermectin, Ivermectin Tablets, Fluvoxamine, Fluvoxamine Maleate Tablets, Fluticasone, Fluticasone Furoate, Placebo, Montelukast, Metformin	Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center	Covid19	04/24	04/24
NCT06042855: ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)	Completed	3	3214	US	Placebo, Metformin	Susanna Naggie, MD, National Center for Advancing Translational Sciences (NCATS), Vanderbilt University Medical Center	Covid19	06/24	11/24
NCT04247542: ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection	Completed	2	53	US	Ibezapolstat, ACX-362E, Vancomycin, Vancomycin oral	Acurx Pharmaceuticals Inc.	Clostridium Difficile Infection	10/23	11/23
BOSS-002, NCT05785390: Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.	Terminated	2	170	US	NP-101, TQ Formula, Placebo	Novatek Pharmaceuticals	COVID-19	05/25	05/25
NCT05732610: MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study	Completed	N/A	34	US	MGC Health COVID-19 & Flu A+B Home Multi Test, MGC Health COVID-19 & Flu A+B Home Multi Test (2 to 13 y/o)	Medical Group Care, LLC, CSSi Life Sciences	COVID-19, Influenza A, Influenza B	02/23	03/23
NCT05771714: Clinical Performance Evaluation of the CareSuperb™ COVID-19 Antigen Home Test	Terminated	N/A	786	US	CareSuperb COVID-19 Antigen Home Test Kit	AccessBio, Inc.	COVID-19	05/23	05/23
ARGONAUT, NCT04638751: Stool and Blood Sample Bank for Cancer Patients	Recruiting	N/A	5000	US	Immunotherapy, Chemotherapy, CRC surgical resection, Colonoscopy	Persephone Biosciences	Non-small Cell Lung Cancer, Colorectal Cancer, Triple Negative Breast Cancer, Pancreas Cancer	12/24	12/25
Villa, Enrique
NCT06372496: Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma	Active, not recruiting	4	1358	Canada, Japan, US, RoW	Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate, Inhaled corticosteroids/long-acting beta-2 agonists	GlaxoSmithKline	Asthma	09/25	03/26
NCT05334758: Clinical Performance Evaluation of the Bio-Self™ COVID-19 Antigen Home Test	Completed	N/A	282	US	Bio-Self COVID-19 Antigen Home Test, Standard of Care COVID-19 Test, RT-PCR Test	BioTeke USA, LLC, CSSi Life Sciences	COVID-19	07/22	07/22
NCT05732610: MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study	Completed	N/A	34	US	MGC Health COVID-19 & Flu A+B Home Multi Test, MGC Health COVID-19 & Flu A+B Home Multi Test (2 to 13 y/o)	Medical Group Care, LLC, CSSi Life Sciences	COVID-19, Influenza A, Influenza B	02/23	03/23
NCT05771714: Clinical Performance Evaluation of the CareSuperb™ COVID-19 Antigen Home Test	Terminated	N/A	786	US	CareSuperb COVID-19 Antigen Home Test Kit	AccessBio, Inc.	COVID-19	05/23	05/23
ARGONAUT, NCT04638751: Stool and Blood Sample Bank for Cancer Patients	Recruiting	N/A	5000	US	Immunotherapy, Chemotherapy, CRC surgical resection, Colonoscopy	Persephone Biosciences	Non-small Cell Lung Cancer, Colorectal Cancer, Triple Negative Breast Cancer, Pancreas Cancer	12/24	12/25
Kim, Hyeonsuk
NCT05771714: Clinical Performance Evaluation of the CareSuperb™ COVID-19 Antigen Home Test	Terminated	N/A	786	US	CareSuperb COVID-19 Antigen Home Test Kit	AccessBio, Inc.	COVID-19	05/23	05/23